Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alcon, Inc.
FDA Approves Alcon’s AcrySof® IQ ReSTOR® +3.0 D Intraocular Lens
January 9th, 2009
Alcon, Inc. (NYSE: ACL), the world’s leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its +3.0 diopter add power AcrySof® IQ ReSTOR® IOL. This new lens, which was introduced in many major markets outside the United States earlier this year, is now approved in the U.S. for cataract surgery in patients with presbyopia. This lens is another technology advancement for the AcrySof® IQ ReSTOR® platform, which has been the number one choice of surgeons to correct presbyopia in cataract patients since it was introduced in 2005. “The introduction of this lens allows me to deliver a full range of quality vision for my...
Source: Health Business Week (2009-01-09)
|
